Literature DB >> 28025617

Denosumab, cancer treatment and risk of osteonecrosis of the jaw.

.   

Abstract

Entities:  

Year:  2013        PMID： 28025617      PMCID： PMC5154241          DOI： 10.1038/bonekey.2013.144

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN： 2047-6396


× No keyword cloud information.
  1 in total

1.  Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials.

Authors:  Wei-Xiang Qi; Li-Na Tang; Ai-Na He; Yang Yao; Zan Shen
Journal:  Int J Clin Oncol       Date:  2013-04-20       Impact factor: 3.402
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.